Tag:   Biopharmaceutical Development

The landscape of modern oncology and regenerative medicine has been fundamentally altered by the advent of personalized therapeutics, yet the industrial frameworks required to...

Progressive advancements in fluid transfer technologies are revolutionizing the way biological products move through the production line. By integrating sophisticated connectors and intelligent sensor technology, fluid transfer innovation in single-use biomanufacturing ensures higher yields, reduced risk of contamination, and a level of process control that meets the stringent demands of modern pharmaceutical standards.

Samsung Bioepis has begun its direct commercialization of Byooviz, which is a biosimilar to Genentech’s Lucentis - ranibizumab in Europe. The company has gone ahead...

Zealand Pharma, OTR Therapeutics sign collaboration through a strategic collaboration and license agreement to discover and develop new therapies for metabolic diseases. The deal...

The U.S. Food and Drug Administration (FDA) has approved inebilizumab-cdon (Uplizna; Amgen) for the treatment of adults with generalized myasthenia gravis who are anti-acetylcholine...